Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium.

Lieven Annemans; Ralph Crott; Diana Degraeve; Dominique Dubois; Michel Huybrechts; Frank Peys; Hugo Robays; Jean Smets; Marc Tomas; Kathleen Vanschoubroek

doi:10.1023/a:1014896830042

Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium.

Identifier:nobleid.org/w1/20260515/5DF7ECC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5DF7ECC3.svg?ark=w1%2F20260515%2F5DF7ECC3)](https://nobleid.org/work/w1/20260515/5DF7ECC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kathleen Vanschoubroek

Claim authorship of this work

Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium.

Identifier:nobleid.org/w1/20260515/5DF7ECC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5DF7ECC3.svg?ark=w1%2F20260515%2F5DF7ECC3)](https://nobleid.org/work/w1/20260515/5DF7ECC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kathleen Vanschoubroek

Claim authorship of this work